While normal 8‐week‐old Sec16a+/+ and Sec16a+/− mice showed no significant pancreatic differences (Figure S3, Supporting Information), cerulein‐treated Sec16a± mice demonstrated significantly increased severity of pancreatitis compared to cerulein‐treated wild‐type mice. This evidence concerns the gene SEC16A and pancreatitis.